FASLG and glioblastoma: APG101 suppressed CD95L-induced cell invasion without altering cell viability in GBM cell lines, reduced tumor growth and matrix metalloproteinase (MMP) activity in combination with radiotherapy in intracranial glioma-bearing mouse models and resulted in longer mouse survival than radiotherapy alone [16,18].